Unibest
← Back to patent-cliff list

CAS 111-45-5

2-[(Prop-2-en-1-yl)oxy]ethan-1-ol

Codes: (I)101438-79-a

Application context (from source-drug indications)

Breast cancerPaclitaxel/Encequidar mesylateAdenocarcinomaPaclitaxel/Encequidar mesylateAngiosarcomaPaclitaxel/Encequidar mesylateSolid tumourPaclitaxel/Encequidar mesylatePancreatic cancerPaclitaxelNon-small cell lung cancerPaclitaxelHodgkin's diseasePaclitaxelSeminomaPaclitaxelOvarian cancerPaclitaxelBreast cancerPaclitaxel

Source drugs (routes using this intermediate)

DrugTierExpiry
Paclitaxel/Encequidar mesylateTier C — Watch / trade-
PaclitaxelTier B — Position early-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Paclitaxel/Encequidar mesylateOptimised routesteps: 3total yield: /
2-[(Prop-2-en-1-yl)oxy]ethan-1-ol→1-Phenyltetrazoline-5-thione→1-Phenyl-5-([2-[(prop-2-en-1-yl)oxy]ethyl]sulfanyl)-1H-tetrazole→1-Phenyl-5-[2-[(prop-2-en-1-yl)oxy]ethanesulfonyl]-1H-tetrazole→(1R*)-2-[(4S*,5S*)-7-Ethenyl-6,6,8-trimethyl-2-oxo-1,3-dioxaspiro[4.5]dec-7-en-4-yl]-1-methylcyclohex-2-ene-1-carbaldehyde→(4S*,5S*)-7-Ethenyl-6,6,8-trimethyl-4-[(6S*)-6-methyl-6-[3-[(prop-2-en-1-yl)oxy]prop-1-en-1-yl]cyclohex-1-en-1-yl]-1,3-dioxaspiro[4.5]dec-7-en-2-one
PaclitaxelOptimised routesteps: 3total yield: /
2-[(Prop-2-en-1-yl)oxy]ethan-1-ol→1-Phenyltetrazoline-5-thione→1-Phenyl-5-([2-[(prop-2-en-1-yl)oxy]ethyl]sulfanyl)-1H-tetrazole→1-Phenyl-5-[2-[(prop-2-en-1-yl)oxy]ethanesulfonyl]-1H-tetrazole→(1R*)-2-[(4S*,5S*)-7-Ethenyl-6,6,8-trimethyl-2-oxo-1,3-dioxaspiro[4.5]dec-7-en-4-yl]-1-methylcyclohex-2-ene-1-carbaldehyde→(4S*,5S*)-7-Ethenyl-6,6,8-trimethyl-4-[(6S*)-6-methyl-6-[3-[(prop-2-en-1-yl)oxy]prop-1-en-1-yl]cyclohex-1-en-1-yl]-1,3-dioxaspiro[4.5]dec-7-en-2-one

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.